Ranbaxy promoters are getting away with a much better deal. It is time SEBI closed this loophole in open offers

The recent corporate action in Ranbaxy is interesting from a minority shareholder point of view. The promoter is selling his entire shareholding to the acquirer at a price that is substantially higher than the ruling market price. The promoter-shareholder will also have some other...